Abstract
Molecular pathways involved in cerebral stroke are diverse. The major pathophysiological events that are observed in stroke comprises of excitotoxicity, oxidative stress, mitochondrial damage, endoplasmic reticulum stress, cellular acidosis, blood–brain barrier disruption, neuronal swelling and neuronal network mutilation. Various biomolecules are involved in these pathways and several major proteins are upregulated and/or suppressed following stroke. Different types of receptors, ion channels and transporters are activated. Fluctuations in levels of various ions and neurotransmitters have been observed. Cells involved in immune responses and various mediators involved in neuro-inflammation get upregulated progressing the pathogenesis of the disease. Despite of enormity of the problem, there is not a single therapy that can limit infarction and neurological disability due to stroke. This is because of poor understanding of the complex interplay between these pathophysiological processes. This review focuses upon the past to present research on pathophysiological events that are involved in stroke and various factors that are leading to neuronal death following cerebral stroke. This will pave a way to researchers for developing new potent therapeutics that can aid in the treatment of cerebral stroke.
Graphical abstract
Similar content being viewed by others
Data availability
Not applicable.
References
Go AS, Mozaffarian D, Roger VL et al (2014) Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129:399–410. https://doi.org/10.1161/01.cir.0000442015.53336.12
Jackevicius CA, Li P, Tu JV et al (2008) Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 117:1028–1036. https://doi.org/10.1161/CIRCULATIONAHA.107.706820
Orset C, Arkelius K, Anfray A et al (2021) Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke. Sci Rep 111(11):1–10. https://doi.org/10.1038/s41598-021-91469-9
Leigh R, Knutsson L, Zhou J, van Zijl PC (2017) Imaging the physiological evolution of the ischemic penumbra in acute ischemic stroke. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678X17700913
Dhapola R, Samir, Beura K et al (2024) Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep 51:1–18. https://doi.org/10.1007/S11033-023-09021-Z
Dhapola R, Subhendu, Hota S et al (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease. Inflammopharmacology 29:1669–1681. https://doi.org/10.1007/S10787-021-00889-6
Kumari S, Dhapola R, Sharma P et al (2023) Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: current progress in molecular signaling and therapeutics. Ageing Res Rev 92:102098. https://doi.org/10.1016/J.ARR.2023.102098
Thakur S, Dhapola R, Sarma P et al (2022) Neuroinflammation in alzheimer’s disease: current progress in molecular signaling and therapeutics. Inflammation. https://doi.org/10.1007/S10753-022-01721-1/TABLES/1
Dhapola R, Sarma P, Medhi B, Prakash A et al (2021) Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for Alzheimer’s disease. Mol Neurobiol 1:1–21. https://doi.org/10.1007/S12035-021-02612-6
Nagar P, Sharma P, Dhapola R et al (2023) Endoplasmic reticulum stress in Alzheimer’s disease: molecular mechanisms and therapeutic prospects. Life Sci. https://doi.org/10.1016/J.LFS.2023.121983
Kumari S, Dhapola R, Reddy DH (2023) Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues. Apoptosis 28:943–957. https://doi.org/10.1007/s10495-023-01848-y
Qin C, Yang S, Chu Y-H et al (2022) Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 7:215. https://doi.org/10.1038/s41392-022-01064-1
Chen Y (2022) Disturbed cerebral circulation and metabolism matters. J Neurochem 160:10–12. https://doi.org/10.1111/JNC.15552
Wang R, Dong Y, Lu Y et al (2019) Photobiomodulation for global cerebral ischemia: targeting mitochondrial dynamics and functions. Mol Neurobiol 56:1852–1869. https://doi.org/10.1007/S12035-018-1191-9/FIGURES/8
Xie Y-F, Macdonald JF, Jackson MF (2010) TRPM2, calcium and neurodegenerative diseases. Int J Physiol Pathophysiol Pharmacol 2:95–103
Fabricius M, Fuhr S, Bhatia R et al (2006) Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain 129:778–790. https://doi.org/10.1093/brain/awh716
Sun Y, Feng X, Ding Y et al (2019) Phased treatment strategies for cerebral ischemia based on glutamate receptors. Front Cell Neurosci 13:168. https://doi.org/10.3389/FNCEL.2019.00168/BIBTEX
Wu L, Xiong X, Wu X et al (2020) Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front Mol Neurosci 13:28. https://doi.org/10.3389/FNMOL.2020.00028
Kago T, Takagi N, Date I, Takenaga Y, Takagi K, ST, (2006) Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 339:1197–1203. https://doi.org/10.1016/J.BBRC.2005.11.133
Zhao X, Zhu L, Liu D et al (2019) Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia/reperfusion injury. Apoptosis 24:157–167. https://doi.org/10.1007/S10495-018-1495-2/FIGURES/8
Tóth OM, Menyhárt Á, Frank R et al (2020) Tissue acidosis associated with ischemic stroke to guide neuroprotective drug delivery. Biology (Basel) 9:460. https://doi.org/10.3390/BIOLOGY9120460
Kaila K, Price TJ, Payne JA et al (2014) Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat Rev Neurosci 15:637–654. https://doi.org/10.1038/nrn3819
Da Silva-Candal A, Maria-Perez-Mato CJ (2022) Treatments against glutamatergic excitotoxicity in ischemic stroke. Glutamate Neuropsychiatr Disord. https://doi.org/10.1007/978-3-030-87480-3_1
Lim D, Semyanov A, Genazzani A, Verkhratsky A (2021) Calcium signaling in neuroglia. Int Rev Cell Mol Biol 362:1–53. https://doi.org/10.1016/BS.IRCMB.2021.01.003
Murphy-Royal C, Dupuis J, Groc L, Oliet SHR (2017) Astroglial glutamate transporters in the brain: regulating neurotransmitter homeostasis and synaptic transmission. J Neurosci Res 95:2140–2151. https://doi.org/10.1002/jnr.24029
Harvey BK, Airavaara M, Hinzman J et al (2011) Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS ONE 6:e22135. https://doi.org/10.1371/journal.pone.0022135
Chen X, Levy JM, Hou A et al (2015) PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density. Proc Natl Acad Sci USA 112:E6983–E6992. https://doi.org/10.1073/pnas.1517045112
Yin X-H, Yana J-Z, Yang G, Chen L, Xiao-Feng X, Hong X-P, Shi-Liang W, Houa X-Y, Zhang GY (2016) PDZ1 inhibitor peptide protects neurons against ischemia via inhibiting GluK2-PSD-95-module-mediated Fas signaling pathway. Brain Res 1637:64–70. https://doi.org/10.1016/J.BRAINRES.2016.02.019
Martins B, Frank D, Zlotnik A et al (2022) The development of novel drug treatments for stroke patients: a review. Int J Mol Sci 23:5796. https://doi.org/10.3390/IJMS23105796
Kimelberg HK, Rutledge E, Goderie S, Charniga C (1995) Astrocytic swelling due to hypotonic or high K+ medium causes inhibition of glutamate and aspartate uptake and increases their release. J Cereb Blood Flow Metab 15:409–416. https://doi.org/10.1038/jcbfm.1995.51
Swanson RA, Farrell K, Simon RP (1995) Acidosis causes failure of astrocyte glutamate uptake during hypoxia. J Cereb Blood Flow Metab 15:417–424. https://doi.org/10.1038/jcbfm.1995.52
Giffard RG, Hannelore DW et al (1990) Selective vulnerability of cultured cortical glia to injury by extracellular acidosis. Brain Res 530:138–141. https://doi.org/10.1016/0006-8993(90)90670-7
de la Rosa DA, Krueger SR, Kolar A et al (2003) Distribution, subcellular localization and ontogeny of ASIC1 in the mammalian central nervous system. J Physiol 546:77–87. https://doi.org/10.1113/jphysiol.2002.030692
Krishtal O (2003) The ASICs: signaling molecules? Modulators? Trends Neurosci 26:477–483. https://doi.org/10.1016/S0166-2236(03)00210-8
Sun H-S, Jackson MF, Martin LJ et al (2009) Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 12:1300–1307. https://doi.org/10.1038/nn.2395
Perraud A-L, Takanishi CL, Shen B et al (2005) Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem 280:6138–6148. https://doi.org/10.1074/jbc.M411446200
Van den Eynde C, Vriens J, De Clercq K (2021) Transient receptor potential channel regulation by growth factors. Biochim Biophys Acta Mol Cell Res 1868:118950. https://doi.org/10.1016/J.BBAMCR.2021.118950
Yamamoto S, Shimizu S, Kiyonaka S et al (2008) TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med 14:738–747. https://doi.org/10.1038/nm1758
Alim I, Teves L, Li R et al (2013) Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death. J Neurosci 33:17264–17277. https://doi.org/10.1523/JNEUROSCI.1729-13.2013
Wu S, Zheng T, Du J et al (2020) Neuroprotective effect of low-intensity transcranial ultrasound stimulation in endothelin-1-induced middle cerebral artery occlusion in rats. Brain Res Bull 161:127–135. https://doi.org/10.1016/J.BRAINRESBULL.2020.05.006
Pedersen SF, O’Donnell ME, Anderson SE, Cala PM (2006) Physiology and pathophysiology of Na+/H+ exchange and Na+–K+ + 2Cl− cotransport in the heart, brain, and blood. Am J Physiol 291:R1-25. https://doi.org/10.1152/ajpregu.00782.2005
Russell JM (2000) Sodium–potassium–chloride cotransport. Physiol Rev 80:211–276
Flatman PW (2008) Cotransporters, WNKs and hypertension: an update. Curr Opin Nephrol Hypertens 17:186–192. https://doi.org/10.1097/MNH.0b013e3282f5244e
Payne JA, Kaila CRJVK (2003) Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci 26:199–206. https://doi.org/10.1016/S0166-2236(03)00068-7
Mercado A, Mount DB, Gamba G (2004) Electroneutral cation-chloride cotransporters in the central nervous system. Neurochem Res 29:17–25. https://doi.org/10.1023/B:NERE.0000010432.44566.21
Yan Y, Dempsey RJ, AndreasFlemmer BD (2003) Inhibition of Na+–K+–Cl− cotransporter during focal cerebral ischemia decreases edema and neuronal damage. Brain Res 961:22–31. https://doi.org/10.1016/S0006-8993(02)03832-5
Buzsáki G, Kai Kaila MR (2007) Inhibition and brain work. Neuron 56:771–783. https://doi.org/10.1016/J.NEURON.2007.11.008
Chen H, Kim GS, Okami N et al (2011) NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiol Dis 42:341–348. https://doi.org/10.1016/j.nbd.2011.01.027
Łagowska-Lenard M, Bielewicz J, Raszewski G et al (2008) Oxidative stress in cerebral stroke. Pol Merkur Lekarski 25:205–208
Kelmanson IV, Shokhina AG, Kotova DA et al (2021) In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox Biol 48:102178. https://doi.org/10.1016/j.redox.2021.102178
Ehresman J, Cottrill E, Caplan JM et al (2021) Neuroprotective role of acidosis in ischemia: review of the preclinical evidence. Mol Neurobiol 58:6684–6696. https://doi.org/10.1007/s12035-021-02578-5
Zhu G, Wang X, Chen L et al (2022) Crosstalk between the oxidative stress and glia cells after stroke: from mechanism to therapies. Front Immunol 13:852416. https://doi.org/10.3389/fimmu.2022.852416
Nagasawa K, Chiba H, Fujita H et al (2006) Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 208:123–132. https://doi.org/10.1002/jcp.20647
Wolburg H (2006) The endothelial frontier. In: Dermietzel R, Spray DC, Nedergaard M (eds) Blood–Brain Barriers. Wiley, Weinheim, pp 75–107
Balda MS, Whitney JA, Flores C et al (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134:1031–1049. https://doi.org/10.1083/JCB.134.4.1031
Nitta T, Hata M, Gotoh S et al (2003) Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice. J Cell Biol 161:653–660. https://doi.org/10.1083/jcb.200302070
Jiang X, Andjelkovic AV, Zhu L et al (2018) Blood–brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 163–164:144–171. https://doi.org/10.1016/J.PNEUROBIO.2017.10.001
Hawkins BT, Davis TP (2005) The blood–brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–185. https://doi.org/10.1124/pr.57.2.4
Yang Y, Estrada EY, Thompson JF et al (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697–709. https://doi.org/10.1038/sj.jcbfm.9600375
Asahi M, Asahi K, Jung J-C et al (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681–1689. https://doi.org/10.1097/00004647-200012000-00007
Chen W, Hartman R, Ayer R et al (2009) Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J Neurochem 111:726–736. https://doi.org/10.1111/j.1471-4159.2009.06362.x
Song Y, Li Q, Long L et al (2015) Asn563Ser polymorphism of CD31/PECAM-1 is associated with atherosclerotic cerebral infarction in a southern Han population. Neuropsychiatr Dis Treat 11:15–20. https://doi.org/10.2147/NDT.S75065
Duong CN, Vestweber D (2020) Mechanisms ensuring endothelial junction integrity beyond VE-cadherin. Front Physiol 11:519. https://doi.org/10.3389/FPHYS.2020.00519/BIBTEX
Zlokovic BV (2008) The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178–201. https://doi.org/10.1016/J.NEURON.2008.01.003
Posada-Duque RA, Barreto GE, Cardona-Gomez GP (2014) Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci 8:231. https://doi.org/10.3389/fncel.2014.00231
Bayir E, Sendemir A (2021) Role of intermediate filaments in blood–brain barrier in health and disease. Cells. https://doi.org/10.3390/CELLS10061400
Ezan P, André P, Cisternino S et al (2012) Deletion of astroglial connexins weakens the blood–brain barrier. J Cereb Blood Flow Metab 32:1457–1467. https://doi.org/10.1038/jcbfm.2012.45
Obenaus A, Badaut J (2022) Role of the non-invasive imaging techniques in monitoring and understanding the evolution of brain edema. J Neurosci Res 100:1191–1200. https://doi.org/10.1002/JNR.24837
Beuker C, Strecker JK, Rawal R et al (2021) Immune cell infiltration into the brain after ischemic stroke in humans compared to mice and rats: a systematic review and meta-analysis. Transl Stroke Res 12:976–990. https://doi.org/10.1007/S12975-021-00887-4/FIGURES/4
Peerschke EI, Wei Yinb BG (2010) Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol 47:2170–2175. https://doi.org/10.1016/J.MOLIMM.2010.05.009
Yilmaz G, Granger DN (2010) Leukocyte recruitment and ischemic brain injury. NeuroMolecular Med 12:193–204. https://doi.org/10.1007/s12017-009-8074-1
Cao Y, Yue X, Jia M, Wang J (2023) Neuroinflammation and anti-inflammatory therapy for ischemic stroke. Heliyon 9:e17986. https://doi.org/10.1016/j.heliyon.2023.e17986
Suresh L, Mehta NMRR (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54:34–66. https://doi.org/10.1016/J.BRAINRESREV.2006.11.003
Marsh BJ (2009) Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158:1007–1020. https://doi.org/10.1016/J.NEUROSCIENCE.2008.07.067
Chen GY, Nuñez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826–837. https://doi.org/10.1038/nri2873
Sugino T, Nozaki K, Hashimoto N (2000) Activation of mitogen-activated protein kinases in gerbil hippocampus with ischemic tolerance induced by 3-nitropropionic acid. Neurosci Lett 278:101–104. https://doi.org/10.1016/S0304-3940(99)00906-4
Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665. https://doi.org/10.1056/NEJMra0910283
Zinnhardt B, Wiesmann M, Honold L et al (2018) In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies—towards clinical translation. Theranostics 8:2603–2620. https://doi.org/10.7150/thno.24128
Zinnhardt B, Viel T, Wachsmuth L et al (2015) Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke. J Cereb blood flow Metab 35:1711–1721. https://doi.org/10.1038/jcbfm.2015.149
Gao Y, Fang C, Wang J et al (2023) Neuroinflammatory biomarkers in the brain, cerebrospinal fluid, and blood after ischemic stroke. Mol Neurobiol 60:5117–5136. https://doi.org/10.1007/s12035-023-03399-4
Doll DN, Barr TL, Simpkins JW (2014) Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis 5:294–306
Priante G, Gianesello L, Ceol M (2019) Cell death in the kidney. Int J Mol Sci. https://doi.org/10.3390/IJMS20143598
Mattson MP (2000) Apoptosis in neurodegenerative disorders—proquest. Humana Press, New Jersey
Nikoletopoulou V, Markaki M, Konstantinos Palikaras NT (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta 1833:3448–3459. https://doi.org/10.1016/J.BBAMCR.2013.06.001
Green DR (2005) Apoptotic pathways: ten minutes to dead. Cell 121:671–674. https://doi.org/10.1016/J.CELL.2005.05.019
Liu Z, Qiu X, Mak S et al (2020) Multifunctional memantine nitrate significantly protects against glutamate-induced excitotoxicity via inhibiting calcium influx and attenuating PI3K/Akt/GSK3beta pathway. Chem Biol Interact 325:109020. https://doi.org/10.1016/J.CBI.2020.109020
Xu B, Xiao A-J, Chen W et al (2016) Neuroprotective effects of a psd-95 inhibitor in neonatal hypoxic-ischemic brain injury. Mol Neurobiol 53:5962–5970. https://doi.org/10.1007/s12035-015-9488-4
Cho Y, Challa S, Moquin D et al (2009) Phosphorylation-driven assembly of the rip1–rip3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112–1123. https://doi.org/10.1016/j.cell.2009.05.037
Zong W-X, Thompson CB (2006) Necrotic death as a cell fate. Genes Dev 20:1–15. https://doi.org/10.1101/gad.1376506
Lee J, Giordano S, Zhang J (2012) Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 441:523–540. https://doi.org/10.1042/BJ20111451
Zalckvar E, Berissi H, Mizrachy L et al (2009) DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep 10:285–292. https://doi.org/10.1038/embor.2008.246
Adhami F, Liao G, Morozov YM, Schloemer A, Schmithorst VJ, Lorenz JN, Dunn RS, Vorhees CV, Wills-Karp M, Degen JL, Davis RJ (2006) Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol 169:566–583. https://doi.org/10.2353/AJPATH.2006.051066
Friedle S, Curet M, Watters J (2010) Recent patents on novel p2x7 receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov 5:35–45. https://doi.org/10.2174/157488910789753530
Ajoolabady A, Wang S, Kroemer G et al (2021) Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics. Pharmacol Ther 225:107848. https://doi.org/10.1016/j.pharmthera.2021.107848
Zhang Q, Jia M, Wang Y et al (2022) Cell death mechanisms in cerebral ischemia-reperfusion injury. Neurochem Res 47:3525–3542. https://doi.org/10.1007/s11064-022-03697-8
Kataoka K, Hayakawa T, Yamada K et al (1989) Neuronal network disturbance after focal ischemia in rats. Stroke 20:1226–1235. https://doi.org/10.1161/01.STR.20.9.1226
Memezawa H, Smith ML, Siesjö BK (1992) Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23:552–559. https://doi.org/10.1161/01.STR.23.4.552
Zhang S-J, Zou M, Lu L et al (2009) Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet 5:e1000604. https://doi.org/10.1371/journal.pgen.1000604
Li Y, Schappell LE, Polizu C et al (2023) Evolving clinical-translational investigations of cerebroprotection in ischemic stroke. J Clin Med. https://doi.org/10.3390/jcm12216715
Lee JS, Lee JS, Gwag BJ et al (2023) The Rescue on reperfusion damage in cerebral infarction by nelonemdaz (rodin) trial: protocol for a double-blinded clinical trial of nelonemdaz in patients with hyperacute ischemic stroke and endovascular thrombectomy. J stroke 25:160–168. https://doi.org/10.5853/jos.2022.02453
Acknowledgements
D.H.K.R is highly thankful to the UGC-BSR (Grant No. F.30-583/2021 (BSR) and Central University of Punjab, Bathinda-Research Seed Money (Grant No. CUPB/CC/PF/20/226) for providing research support. R.D is recipients of research fellowship from the Department of Science and Technology DST-INSPIRE (Reg. No. IF210098).
Funding
None.
Author information
Authors and Affiliations
Contributions
D.H.K.R and B.M designed the manuscript. D.H.K.R and R.D wrote the manuscript and prepared the illustrated figures, and tables. D.H.KR. and B.M revised the manuscript for important intellectual content. All authors read and approved the final manuscript. All persons designated as authors qualify for author-ship, and all those who qualify for authorship are listed.
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest.
Ethical approval
Not applicable.
Compliance with ethical standards
Yes.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dhapola, R., Medhi, B. & HariKrishnaReddy, D. Insight into the pathophysiological advances and molecular mechanisms underlying cerebral stroke: current status. Mol Biol Rep 51, 649 (2024). https://doi.org/10.1007/s11033-024-09597-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11033-024-09597-0